Riaz Muhammad, Khalid Ramsha, Afzal Muhammad, Anjum Fozia, Fatima Hina, Zia Saadiya, Rasool Ghulam, Egbuna Chukwuebuka, Mtewa Andrew G, Uche Chukwuemelie Zedech, Aslam Muhammad Aamir
Department of Allied Health Sciences University of Sargodha Sargodha Pakistan.
Department of Biochemistry University of Agriculture Faisalabad Pakistan.
Food Sci Nutr. 2023 Apr 17;11(6):2500-2529. doi: 10.1002/fsn3.3308. eCollection 2023 Jun.
Phytobioactive compounds are plant secondary metabolites and bioactive compounds abundantly present in medicinal plants and have remarkable therapeutic potential. Oxidative stress and antibiotic resistance are major causes of present-day ailments such as diabetes, atherosclerosis, cardiovascular disorders, cancer, and inflammation. The data for this review were collected from Google Scholar, PubMed, Directory of Open Access Journals (DOAJ), and Science Direct by using keywords: "Medicinal plants, Phytobioactive compounds, Polyphenols, Alkaloids, Carotenoids etc." Several studies have reported the pharmacological and therapeutic potential of the phytobioactives. Polyphenols, alkaloids, terpenes, and polysaccharides isolated from medicinal plants showed remarkable antioxidant, anticancer, cytotoxic, anti-inflammatory, cardioprotective, hepatoprotective, immunomodulatory, neuroprotective, and antidiabetic activities. This literature review was planned to provide comprehensive insight into the biopharmacological and therapeutic potential of phytobioactive compounds. The techniques used for the extraction and isolation of phytobioactive compounds, and bioassays required for their biological activities such as antioxidant, antimicrobial, anti-inflammatory, and cytotoxic activities, have been discussed. Characterization techniques for the structural elucidation of phytobioactive compounds such as HPLC, TLC, FTIR, GC-MS/MS, and NMR have also been discussed. This review concludes that phytobioactive compounds may be used as potential alternative to synthetic compounds as therapeutic agents for the treatment of various diseases.
植物生物活性化合物是植物次生代谢产物和生物活性化合物,大量存在于药用植物中,具有显著的治疗潜力。氧化应激和抗生素耐药性是当今疾病如糖尿病、动脉粥样硬化、心血管疾病、癌症和炎症的主要原因。本综述的数据通过使用关键词“药用植物、植物生物活性化合物、多酚、生物碱、类胡萝卜素等”从谷歌学术、PubMed、开放获取期刊目录(DOAJ)和科学Direct收集。多项研究报道了植物生物活性物质的药理和治疗潜力。从药用植物中分离出的多酚、生物碱、萜类和多糖表现出显著的抗氧化、抗癌、细胞毒性、抗炎、心脏保护、肝脏保护、免疫调节、神经保护和抗糖尿病活性。本综述旨在全面深入了解植物生物活性化合物的生物药理学和治疗潜力。讨论了用于提取和分离植物生物活性化合物的技术,以及其生物活性如抗氧化、抗菌、抗炎和细胞毒性活性所需的生物测定方法。还讨论了用于植物生物活性化合物结构解析的表征技术,如高效液相色谱法(HPLC)、薄层色谱法(TLC)、傅里叶变换红外光谱法(FTIR)、气相色谱-串联质谱法(GC-MS/MS)和核磁共振法(NMR)。本综述得出结论,植物生物活性化合物可作为合成化合物的潜在替代品,用作治疗各种疾病的治疗剂。